The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Sanders, Jan-Stephan FBemelman, Frederike JMesschendorp, A LianneBaan, Carla Cvan Baarle, Debbievan Binnendijk, RobDiavatopoulos, Dimitri AFrölke, Sophie CGeers, DarylGeurtsvanKessel, Corine Hden Hartog, Gercovan der Heiden, MariekeImhof, CelineKho, Marcia M LKoopmans, Marion P GMalahe, S Reshwan KMattheussens, Wouter Bvan der Molen, Renatevan Mourik, DjenolanRemmerswaal, Ester B MRots, NynkeVart, Priyade Vries, Rory DGansevoort, Ron THilbrands, Luuk BReinders, Marlies E J2022-08-072022-08-073475389410.1097/TP.0000000000003983http://hdl.handle.net/10029/625986enCopyright © 2021 The Author(s).The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.Article1534-6080Transplantation 2022 ; 106(4):821-34